| 000 | 01741 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514222722.0 | ||
| 264 | 0 | _c20051028 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1524-4539 | ||
| 024 | 7 |
_a10.1161/01.CIR.0000160360.02040.AB _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerl, Sabine | |
| 245 | 0 | 0 |
_aTargeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. _h[electronic resource] |
| 260 |
_bCirculation _cApr 2005 |
||
| 300 |
_a1583-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCoxsackievirus Infections _xdrug therapy |
| 650 | 0 | 4 |
_aCysteine Endopeptidases _xgenetics |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aEnterovirus _xenzymology |
| 650 | 0 | 4 |
_aGene Expression Regulation, Viral _xdrug effects |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Interferon _xdeficiency |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aViral Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aVirulence |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aMichaelis, Cornelia | |
| 700 | 1 | _aJaschke, Birgit | |
| 700 | 1 | _aVorpahl, Marc | |
| 700 | 1 | _aSeidl, Stefan | |
| 700 | 1 | _aWessely, Rainer | |
| 773 | 0 |
_tCirculation _gvol. 111 _gno. 13 _gp. 1583-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.CIR.0000160360.02040.AB _zAvailable from publisher's website |
| 999 |
_c15466046 _d15466046 |
||